Selectivity of Digitalis Glycosides for Isoforms of Human Na,K-ATPase*
暂无分享,去创建一个
Elizabeta Bab-Dinitz | A. Katz | S. Karlish | R. Goldshleger | D. Tal | Adriana Katz | Yael Lifshitz | Einat Kapri-Pardes | Rivka Goldshleger | Daniel M Tal | Steven J D Karlish | Elizabeta Bab-Dinitz | Y. Lifshitz | Einat Kapri-Pardes
[1] J. Lingrel,et al. Ouabain and substrate affinities of human Na+-K+-ATPase α1β1, α2β1, and α3β1when expressed separately in yeast cells , 2001 .
[2] V. Herrera,et al. Immunologic identification of Na+,K(+)-ATPase isoforms in myocardium. Isoform change in deoxycorticosterone acetate-salt hypertension. , 1994, Circulation research.
[3] M. Nesher,et al. Diverse biological responses to different cardiotonic steroids. , 2007, Pathophysiology : the official journal of the International Society for Pathophysiology.
[4] G. Scheiner-Bobis,et al. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. , 2007, American journal of physiology. Cell physiology.
[5] C. Toyoshima,et al. Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain , 2009, Proceedings of the National Academy of Sciences.
[6] M. Masnyk,et al. The lead structure in cardiac glycosides is 5 β,14 β-androstane-3 β,14-diol , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[7] J. Lingrel,et al. Physiological role of the α1- and α2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site , 2006 .
[8] J. Lingrel. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase. , 2010, Annual review of physiology.
[9] C. Toyoshima,et al. Crystal structure of the sodium–potassium pump at 2.4 Å resolution , 2009, Nature.
[10] P. Manunta,et al. Ouabain‐induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure , 1994, Journal of hypertension.
[11] B. Forbush. Cardiotonic Steroid Binding to Na,K-ATPase , 1983 .
[12] A. From,et al. Interaction of (Na+,K+)-ATPases and digitalis genins. A general model for inhibitory activity. , 1983, The Journal of biological chemistry.
[13] K. Gottschalk,et al. Expression of Na+,K+-ATPase in Pichia pastoris , 2003, Journal of Biological Chemistry.
[14] C. Ebel,et al. Purification of Na+,K+-ATPase Expressed in Pichia pastoris Reveals an Essential Role of Phospholipid-Protein Interactions* , 2005, Journal of Biological Chemistry.
[15] A. From,et al. Cardiac glycosides. 6. Gitoxigenin C16 acetates, formates, methoxycarbonates, and digitoxosides. Synthesis and Na+,K+-ATPase inhibitory activities. , 1986, Journal of medicinal chemistry.
[16] M. Blaustein,et al. How does salt retention raise blood pressure? , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[17] M. Tabet,et al. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition. , 2005, Biochemistry.
[18] P. Manunta,et al. Structure-Activity Relationships for the Hypertensinogenic Activity of Ouabain: Role of the Sugar and Lactone Ring , 2001, Hypertension.
[19] D. Bers,et al. Differential distribution and regulation of mouse cardiac Na+/K+-ATPase α1 and α2 subunits in T-tubule and surface sarcolemmal membranes , 2007 .
[20] A. McDonough,et al. All human Na+-K+-ATPase α-subunit isoforms have a similar affinity for cardiac glycosides , 2001 .
[21] M. Blaustein,et al. Sodium pump α2 subunits control myogenic tone and blood pressure in mice , 2005 .
[22] H. Garty,et al. Purification of the human alpha2 Isoform of Na,K-ATPase expressed in Pichia pastoris. Stabilization by lipids and FXYD1. , 2007, Biochemistry.
[23] P. A. Pedersen,et al. Consequences of mutations to the phosphorylation site of the alpha-subunit of Na, K-ATPase for ATP binding and E1-E2 conformational equilibrium. , 1996, Biochemistry.
[24] Jean-Daniel Horisberger,et al. Transport and Pharmacological Properties of Nine Different Human Na,K-ATPase Isozymes* , 2000, The Journal of Biological Chemistry.
[25] D. Bers. Calcium cycling and signaling in cardiac myocytes. , 2008, Annual review of physiology.
[26] R. Kiss,et al. Na+/K+-ATPase α subunits as new targets in anticancer therapy , 2008 .
[27] R. Schwinger,et al. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1. , 2009, European journal of pharmacology.
[28] Zijian Xie,et al. The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades , 2008, Pflügers Archiv - European Journal of Physiology.
[29] D. Bers,et al. Functional analysis of Na+/K+-ATPase isoform distribution in rat ventricular myocytes. , 2007, American journal of physiology. Cell physiology.
[30] H. Brismar,et al. Ouabain, a steroid hormone that signals with slow calcium oscillations , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] Zijian Xie,et al. Na(+)/K(+)-ATPase as a signal transducer. , 2002, European journal of biochemistry.
[32] M. Blaustein,et al. The Pump, the Exchanger, and Endogenous Ouabain: Signaling Mechanisms That Link Salt Retention to Hypertension , 2009, Hypertension.
[33] M. Blaustein,et al. Na+ pump low and high ouabain affinity alpha subunit isoforms are differently distributed in cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. From,et al. Cardiac glycosides. 7. Sugar stereochemistry and cardiac glycoside activity. , 1986, Journal of medicinal chemistry.
[35] H. Garty,et al. Role of FXYD proteins in ion transport. , 2006, Annual review of physiology.
[36] J. Shapiro,et al. Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets , 2009, Pharmacological Reviews.
[37] A. From,et al. Digitalis receptor sugar binding site characteristics: A model based upon studies of Na+, K+-ATPase preparations with differing digitalis sensitivities , 1990, Molecular and Cellular Biochemistry.
[38] M. Rich,et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. , 2006, European heart journal.
[39] R. Schwinger,et al. Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle. , 2001, Cellular and molecular biology.
[40] S. Karlish,et al. Stabilization of Na(+),K(+)-ATPase purified from Pichia pastoris membranes by specific interactions with lipids. , 2007, Biochemistry.
[41] K. Repke,et al. Differentiation between isoforms of Na+/K+-transporting ATPase from human and guinea-pig cardiac muscle through use of digitalis derivatives as analytical probes , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.